Sacituzumab govitecan (solution)
CAT:
804-HY-132254A-06
Size:
50 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: Yes
Sacituzumab govitecan (solution)
- Product Name Alternative: IMMU-132 (solution)
- CAS Number: 1491917-83-9
- UNSPSC Description: Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity[1].
- Target Antigen: Antibody-Drug Conjugates (ADCs); TROP2
- Type: ADC Related
- Related Pathways: Antibody-drug Conjugate/ADC Related;Immunology/Inflammation
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/sacituzumab-govitecan-solution.html
- Purity: 96.61
- Solubility: 10 mM in DMSO
- Smiles: [Sacituzumab govitecan (solution)]
- References & Citations: [1]Cardillo TM, et al. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug Chem. 2015 May 20;26(5):919-31.|[2]Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) [published correction appears in Oncotarget. 2020 Mar 10;11(10):942]. Oncotarget. 2015;6(26):22496-22512.
- Shipping Conditions: Dry Ice
- Storage Conditions: -80°C, protect from light
- Clinical Information: Phase 2